Our research has observed changes in VCAM-1 expression in response to GBM spheroids and U-87 MG glioblastoma cells to G721–0282 treatment, mainly at concentrations of 100–25 μM, which could be explained by VCAM-1/IL-1β dependence. Here, IL1B is linked to glioblastoma.